IRON Disc Medicine, Inc.
$79.90▲ +2.88%
Healthcare
Other
After hours
$80.00▲ +0.13%
Oct 27, 4:00 PM ET
Volume 1.47M
Avg Volume (10D) 2.24M
Key Metrics & Fundamentals
Market Cap
$3.55B
P/E Ratio
–
Div Yield
0.00%
52W Range
40.00 - 99.50
% vs 50 MA
12.20%
% vs 200 MA
13.16%
RSI-14
66.7
MACD Histogram
+2.3400
Beta (1Y vs SPY)
0.81
Free Cash Flow
-$44.20M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$58.47M
COGS
–
Operating Exp
$65.08M
Operating Income
-$65.08M
EBIT
-$65.08M
Pretax Income
-$59.46M
Net Income
-$59.53M
EPS (Diluted)
-1.54
Price & Volume History
Loading chart…
Recent News
iShares Russell 2000 (IWM) Buys $8.5 Million More Disc Medicine on Friday
GuruFocus.com · Oct 27, 2026 7:04 AM ET
Disc Medicine Delivers Promise For Patients with Sunlight Sensitivity In Successful Pivotal Study
Benzinga · Oct 21, 2026 11:30 PM ET
Disc Medicine Prices $450 Million Upsized Public Offering
MT Newswires · Oct 21, 2026 3:23 AM ET
Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock
GlobeNewswire · Oct 20, 2026 8:52 PM ET
A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
CNW Group · Oct 20, 2026 8:59 AM ET
Disc Medicine Stock Jumps After Phase 3 Trial Success And FDA Refiling Plan
Simply Wall St. · Oct 19, 2026 9:20 PM ET
Disc Medicine Launches $350 Million Securities Offering
MT Newswires · Oct 19, 2026 4:35 PM ET
Disc Medicine (IRON) APOLLO Win Puts Its Valuation Discount Back In Focus
Simply Wall St. · Oct 19, 2026 4:13 PM ET
Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire · Oct 19, 2026 4:01 PM ET
What Could Disc Medicine (IRON) Reveal From Its Phase 3 APOLLO Trial?
Simply Wall St. · Oct 19, 2026 3:20 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IRON's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.